IL-1β expression is upregulated in the brain of AD patients, and inhibition of the activation of NLRP3 inflammasome can improve the behavioral abnormalities and synaptic pathological phenotype in AD mice (39). This evidence concerns the gene NLRP3 and Alzheimer disease.